MONTREAL--(BUSINESS WIRE)--June 8, 2006--The annual general meeting of the shareholders of Nymox Pharmaceutical Corporation (NASDAQ: NYMX - News) was highlighted by an update and review of current product development by the Company’s President and CEO, Dr. Paul Averback. Newly elected to the Board of Directors were Professor David Morse, Ph.D., Roger Guy, M.D., Paul F. McDonald, and Randall Lanham.
